Glucoses

<p>Azenosertib (ZN-c3) is an orally active, specific GPR119 agonist. Cost-effective and quality-assured.</p>

<p>Sucrose (D-(+)-Saccharose) is a nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons.</p>

<p>1.</p>

<p>1-Deoxynojirimycin (Moranoline) is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.</p>

<p>AS1269574 is a potent, orally available GPR119 agonist. AS1269574(AS 1269574) has the potential for the research of type 2 diabetes.</p>

<p>Ponalrestat is an aldose reductase inhibitor.</p>

<p>BMS309403 is a potent and selective inhibitor of adipocyte fatty acid binding protein aFABP.Cost-effective and quality-assured.</p>

<p>STF-31 is an inhibitor of glucose transporter 1 (GLUT1) with IC50 of 1 μM.</p>

<p>Stability Hygroscopic, Light Sensitive, Temperature Sensitive<br>Applications An intermediate in the Maillard reaction of proteins with glucose, which is metabolised to 3-Deoxyfructose. An intermediate in the formation of pyrraline, which might contribute to a pathological effect, such as carcinogenesis.<br>References Kato, H. et al.: Agric. Biol. Chem., 51, 683 (1987), Hayase, F. et al.: J. Biol. Chem., 264, 3758 (1989), Kato, H. et al.: Biochimica et Biophysica Acta, 1035, 71 (1990)<br></p>

<p>Applications D-Glucose is a simple sugar that is present in plants. A monosaccharide that may exist in open chain or cyclic conformation if in solution. It plays a vital role in photosynthesis and fuels the energy required for cellular respiration. D-Glucose is used in various metabolic processes including enzymic synthesis of cyclohexyl-α and β-D-glucosides. Can also be used as a diagnostic tool in detection of type 2 diabetes mellitus and potentially Huntington's disease through analysis of blood-glucose in type 1 diabetes mellitus.<br>References Wang, R., et al.: J. Mol. Catal. B. Enz., 56, 131 (2009); Springhorn, C. et al.: J. Clin. Endocrinol. Metab., 97, 4640 (2012); Hashimoto, K. et al.: J. Clin. Endocrinol. Metab., 97, 3016 (2012); Avelange, M. et al.: Plant. Phys., 94, 1157 (1990); Cramer, C. et al.: J. Chem. Soc., 115, 5745 (1993);<br></p>

<p>Applications A radiolabelled pharmaceutical preparation for diagnostic aims used in positron emission tomography.<br>References Chirakal, R., et al.: Applied Radiation Isotopes, 46, 149 (1995), Kuge, Y., et al.: Nuclear Med. Biol., 29, 275 ( 2002),<br></p>